Fred E Cohen

NTLA

Fred E Cohen serves as Director at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.40M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$1.40M

Companies Traded

NTLA

Active Period

Jan 2026

1 total trades

Most Recent

Buy NTLA

Jan 5, 2026 · $1.40M

Fred E Cohen's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

1 · $1.40M

Sells

0 · $0.00

Total Shares Bought

150,000

Total Shares Sold

NTLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026↗	Buy	150,000	$9.35	$1.40M	0

Related Insiders

Eliana Clark

officer: EVP, Chief Technical Officer

NTLASell · Mar 3, 2026

BASTA JAMES

officer: EVP, General Counsel

NTLASell · Mar 3, 2026

Birgit C Schultes

EVP, Chief Scientific Officer

NTLASell · Jan 5, 2026

David Lebwohl

EVP, Chief Medical Officer

NTLASell · Jan 5, 2026

LEONARD JOHN M

President and CEO

NTLASell · Jan 5, 2026

BASTA JAMES

EVP, General Counsel

NTLASell · Jan 5, 2026

Eliana Clark

EVP, Chief Technical Officer

NTLASell · Jan 5, 2026

Michael P Dube

VP, Chief Accounting Officer

NTLASell · Jan 5, 2026

Explore More Insider Trading Data

NTLA Insider Trading Activity

View all insider trades at Intellia Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity